Deborah H. Telman - Aug 1, 2022 Form 3 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Stock symbol
GILD
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
3
Date filed
8/5/2022, 07:22 PM
Previous filing
May 27, 2022
Next filing
Feb 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GILD Non-qualified Stock Option (Right to Buy) Aug 1, 2022 Common Stock 48.6K $60.75 Direct F2
holding GILD Restricted Stock Unit Aug 1, 2022 Common Stock 24.7K Direct F1, F3
holding GILD Restricted Stock Unit Aug 1, 2022 Common Stock 8.23K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The restricted stock units have a three-year vesting schedule. 1/3 vest on each yearly anniversary of the date of grant until fully vested.
F4 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.